Celularity Stock (NASDAQ: CELU) stock price, news, charts, stock research, profile.
You can purchase shares of Celularity (NASDAQ:CELU) through any online brokerage.
Other companies in Celularity’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Serina Therapeutics (AMEX:SER), Fortress Biotech (NASDAQ:FBIO), Kezar Life Sciences (NASDAQ:KZR) and Intensity Therapeutics (NASDAQ:INTS).
Celularity has a consensus price target of $6.13.
The stock price for Celularity (NASDAQ: CELU) is $2.26 last updated January 13, 2025 at 8:50 AM EST.
There are no upcoming dividends for Celularity.
Celularity’s Q3 earnings are confirmed for Friday, December 6, 2024.
There is no upcoming split for Celularity.
Celularity is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.